Atlas Trials

Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation

Clinical trial NCT03110900 · TERMINATED

Trial details

NCT number
NCT03110900
Sponsor
University of Arkansas
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Agitation,PsychomotorHaloperidol Causing Adverse Effects in Therapeutic UseLorazepam Causing Adverse Effects in Therapeutic UseLoxapine Causing Adverse Effects in Therapeutic Use
Start date
2017-09-30
Primary completion
2018-04-04
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.